Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.585 USD | -3.35% | -12.22% | -33.05% |
Mar. 27 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.05% | 106M | |
-2.90% | 103B | |
+1.27% | 95.28B | |
+1.46% | 22.15B | |
-16.10% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.31% | 16.05B | |
+4.83% | 13.68B | |
+33.11% | 12.17B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- Capital One Initiates GlycoMimetics With Overweight Rating, Price Target is $12